M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT03840902 · TERMINATED
Trial details
- NCT number
- NCT03840902
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2023-02-17
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.